Cargando…

Modulation of Paracellular-like Drug Transport across an Artificial Biomimetic Barrier by Osmotic Stress-Induced Liposome Shrinking

Various types of artificial biomimetic barriers are widely utilized as in vitro tools to predict the passive “transcellular” transport of drug compounds. The current study investigated if the sandwich barrier PermeaPad(®), which is composed of tightly packed phospholipid vesicles enclosed between tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksen, Jonas Borregaard, Barakat, Hesham, Luppi, Barbara, Brandl, Martin, Bauer-Brandl, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027509/
https://www.ncbi.nlm.nih.gov/pubmed/35456555
http://dx.doi.org/10.3390/pharmaceutics14040721
_version_ 1784691383137730560
author Eriksen, Jonas Borregaard
Barakat, Hesham
Luppi, Barbara
Brandl, Martin
Bauer-Brandl, Annette
author_facet Eriksen, Jonas Borregaard
Barakat, Hesham
Luppi, Barbara
Brandl, Martin
Bauer-Brandl, Annette
author_sort Eriksen, Jonas Borregaard
collection PubMed
description Various types of artificial biomimetic barriers are widely utilized as in vitro tools to predict the passive “transcellular” transport of drug compounds. The current study investigated if the sandwich barrier PermeaPad(®), which is composed of tightly packed phospholipid vesicles enclosed between two support sheets, contributes to a transport mechanism that is paracellular-like, representing one of the alternative pathways of passive transport in vivo, primarily of relevance for hydrophilic drug compounds. To this end, we pretreated the commercial PermeaPad(®) barrier with NaCl solutions of either high or low osmolality prior to permeation experiments on reversed Franz cell setups with hydrophilic model compounds calcein and acyclovir and hydrophobic model compounds hydrocortisone and celecoxib. Our starting hypothesis was that the liposomes formed in the barrier during the hydration step should either shrink or swell upon contact with test media (drug solutions) due to osmotic pressure difference as compared to the pretreatment solutions. Apparent permeabilities for calcein and acyclovir across the PermeaPad(®) barrier were found to increase approximately 2.0 and 1.7 fold, respectively, upon hypo-osmotic pretreatment (soaking in hypotonic medium, while the permeation of hydrocortisone and celecoxib remained unchanged. A control experiment with lipid-free barriers (support sheets) indicated that the permeation of all the compounds was virtually unchanged upon hypo-osmotic pretreatment. In conclusion, soaking PermeaPad(®) in a medium of lower osmotic pressure than that used during the permeation study appears to induce the osmotic shrinking of the lipid vesicles in the barrier, leaving wider water channels between the vesicles and, thus, allowing hydrophilic compounds to pass the barrier in a paracellular-like manner.
format Online
Article
Text
id pubmed-9027509
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90275092022-04-23 Modulation of Paracellular-like Drug Transport across an Artificial Biomimetic Barrier by Osmotic Stress-Induced Liposome Shrinking Eriksen, Jonas Borregaard Barakat, Hesham Luppi, Barbara Brandl, Martin Bauer-Brandl, Annette Pharmaceutics Article Various types of artificial biomimetic barriers are widely utilized as in vitro tools to predict the passive “transcellular” transport of drug compounds. The current study investigated if the sandwich barrier PermeaPad(®), which is composed of tightly packed phospholipid vesicles enclosed between two support sheets, contributes to a transport mechanism that is paracellular-like, representing one of the alternative pathways of passive transport in vivo, primarily of relevance for hydrophilic drug compounds. To this end, we pretreated the commercial PermeaPad(®) barrier with NaCl solutions of either high or low osmolality prior to permeation experiments on reversed Franz cell setups with hydrophilic model compounds calcein and acyclovir and hydrophobic model compounds hydrocortisone and celecoxib. Our starting hypothesis was that the liposomes formed in the barrier during the hydration step should either shrink or swell upon contact with test media (drug solutions) due to osmotic pressure difference as compared to the pretreatment solutions. Apparent permeabilities for calcein and acyclovir across the PermeaPad(®) barrier were found to increase approximately 2.0 and 1.7 fold, respectively, upon hypo-osmotic pretreatment (soaking in hypotonic medium, while the permeation of hydrocortisone and celecoxib remained unchanged. A control experiment with lipid-free barriers (support sheets) indicated that the permeation of all the compounds was virtually unchanged upon hypo-osmotic pretreatment. In conclusion, soaking PermeaPad(®) in a medium of lower osmotic pressure than that used during the permeation study appears to induce the osmotic shrinking of the lipid vesicles in the barrier, leaving wider water channels between the vesicles and, thus, allowing hydrophilic compounds to pass the barrier in a paracellular-like manner. MDPI 2022-03-28 /pmc/articles/PMC9027509/ /pubmed/35456555 http://dx.doi.org/10.3390/pharmaceutics14040721 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Eriksen, Jonas Borregaard
Barakat, Hesham
Luppi, Barbara
Brandl, Martin
Bauer-Brandl, Annette
Modulation of Paracellular-like Drug Transport across an Artificial Biomimetic Barrier by Osmotic Stress-Induced Liposome Shrinking
title Modulation of Paracellular-like Drug Transport across an Artificial Biomimetic Barrier by Osmotic Stress-Induced Liposome Shrinking
title_full Modulation of Paracellular-like Drug Transport across an Artificial Biomimetic Barrier by Osmotic Stress-Induced Liposome Shrinking
title_fullStr Modulation of Paracellular-like Drug Transport across an Artificial Biomimetic Barrier by Osmotic Stress-Induced Liposome Shrinking
title_full_unstemmed Modulation of Paracellular-like Drug Transport across an Artificial Biomimetic Barrier by Osmotic Stress-Induced Liposome Shrinking
title_short Modulation of Paracellular-like Drug Transport across an Artificial Biomimetic Barrier by Osmotic Stress-Induced Liposome Shrinking
title_sort modulation of paracellular-like drug transport across an artificial biomimetic barrier by osmotic stress-induced liposome shrinking
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027509/
https://www.ncbi.nlm.nih.gov/pubmed/35456555
http://dx.doi.org/10.3390/pharmaceutics14040721
work_keys_str_mv AT eriksenjonasborregaard modulationofparacellularlikedrugtransportacrossanartificialbiomimeticbarrierbyosmoticstressinducedliposomeshrinking
AT barakathesham modulationofparacellularlikedrugtransportacrossanartificialbiomimeticbarrierbyosmoticstressinducedliposomeshrinking
AT luppibarbara modulationofparacellularlikedrugtransportacrossanartificialbiomimeticbarrierbyosmoticstressinducedliposomeshrinking
AT brandlmartin modulationofparacellularlikedrugtransportacrossanartificialbiomimeticbarrierbyosmoticstressinducedliposomeshrinking
AT bauerbrandlannette modulationofparacellularlikedrugtransportacrossanartificialbiomimeticbarrierbyosmoticstressinducedliposomeshrinking